139 related articles for article (PubMed ID: 1678420)
1. Somatostatin cerebrospinal fluid levels in dementia.
Molins A; Catalán R; Sahuquillo J; Castellanos JM; Codina A; Galard R
J Neurol; 1991 Jun; 238(3):168-70. PubMed ID: 1678420
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid somatostatin in delirium.
Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptides in cerebrospinal fluid in normal-pressure hydrocephalus and dementia.
Wikkelsö C; Ekman R; Westergren I; Johansson B
Eur Neurol; 1991; 31(2):88-93. PubMed ID: 1675171
[TBL] [Abstract][Full Text] [Related]
4. CSF somatostatin-like immunoreactivity in dementia.
Beal MF; Growdon JH; Mazurek MF; Martin JB
Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.
Atack JR; Beal MF; May C; Kaye JA; Mazurek MF; Kay AD; Rapoport SI
Arch Neurol; 1988 Mar; 45(3):269-74. PubMed ID: 2893600
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
Minthon L; Edvinsson L; Gustafson L
Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
[TBL] [Abstract][Full Text] [Related]
7. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Nilsson CL; Brinkmalm A; Minthon L; Blennow K; Ekman R
Peptides; 2001 Dec; 22(12):2105-12. PubMed ID: 11786197
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid neuropeptides in mood disorder and dementia.
Banki CM; Karmacsi L; Bissette G; Nemeroff CB
J Affect Disord; 1992 May; 25(1):39-45. PubMed ID: 1352520
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the course of senile dementia of the Alzheimer type using cerebrospinal fluid levels of acetylcholinesterase and somatostatin.
Urakami K; Adachi Y; Awaki E; Takahashi K
Acta Neurol Scand; 1989 Sep; 80(3):232-7. PubMed ID: 2572139
[TBL] [Abstract][Full Text] [Related]
10. CSF somatostatin in Alzheimer's disease.
Serby M; Richardson SB; Twente S; Siekierski J; Corwin J; Rotrosen J
Neurobiol Aging; 1984; 5(3):187-9. PubMed ID: 6151123
[TBL] [Abstract][Full Text] [Related]
11. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
[TBL] [Abstract][Full Text] [Related]
12. Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus?
Brettschneider J; Riepe MW; Petereit HF; Ludolph AC; Tumani H
J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1614-6. PubMed ID: 15489398
[TBL] [Abstract][Full Text] [Related]
13. Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
Wood PL; Etienne P; Lal S; Gauthier S; Cajal S; Nair NP
Life Sci; 1982 Nov; 31(19):2073-9. PubMed ID: 6184590
[No Abstract] [Full Text] [Related]
14. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
[TBL] [Abstract][Full Text] [Related]
15. Dementia--and adenylate kinase activity in cerebrospinal fluid.
Ahlberg J; Blomstrand C; Ronquist G; Wikkelsö C
Acta Neurol Scand; 1985 Nov; 72(5):525-7. PubMed ID: 4082920
[TBL] [Abstract][Full Text] [Related]
16. Peptide histidine methionine in cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
Yasuda M; Minamitani N; Maeda K
Jpn J Psychiatry Neurol; 1993 Mar; 47(1):85-90. PubMed ID: 8105129
[TBL] [Abstract][Full Text] [Related]
17. GH response to GH-releasing hormone (GHRH) in Alzheimer and vascular dementia. Relation with somatostatin cerebrospinal levels.
Gómez IM; Aguilar M; Navarro MA; Ortolà J; Soler J
Ann Endocrinol (Paris); 1996; 57(2):107-10. PubMed ID: 8881289
[TBL] [Abstract][Full Text] [Related]
18. Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia.
Mochizuki Y; Oishi M; Hara M; Takasu T
Ann Clin Lab Sci; 1996; 26(3):275-8. PubMed ID: 8726221
[TBL] [Abstract][Full Text] [Related]
19. Patients with Alzheimer's disease show an increased content of 15 Kdalton somatostatin precursor and a lowered level of tetradecapeptide in their cerebrospinal fluid.
Gomez S; Puymirat J; Valade P; Davous P; Rondot P; Cohen P
Life Sci; 1986 Aug; 39(7):623-7. PubMed ID: 2874467
[TBL] [Abstract][Full Text] [Related]
20. Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type.
Martinez M; Frank A; Hernanz A
J Neuroimmunol; 1993; 48(2):235-40. PubMed ID: 7693756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
